Navigation Links
NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
Date:11/6/2007

$39 $74 11.1% 8.8% 2.5% 1.6x

Long-Term Care $284 $81 11.5% 8.5% 2.2% 1.9x

Medical Office $79 $174/sf 7.2% 7.2%

Subtotal $638

Loans $47 11.0%

Total $685

Included in these numbers are third party investments financed through our unconsolidated joint venture which are broken out in the supplemental information package (which exclude the twelve facilities acquired by the joint venture from us for $143 million during 2007). Approximately 75% of the acquired loans mature in 2007 and 2008.

2007 FINANCING TRANSACTIONS

During the first nine months of 2007, we issued approximately 5.3 million shares through our controlled equity offering program at an average price of $31.44 per share resulting in net proceeds of approximately $164 million.

On October 1, 2007, we redeemed all 900,485 shares of our Series A Cumulative Preferred Step-Up REIT Securities at their $100 per share redemption value for a total of $90,048,500. The final dividend on these shares was paid concurrently.

On October 19, 2007, we issued $300 million of 6.25% senior unsecured notes maturing on February 1, 2013, resulting in net proceeds of approximately $297 million after deducting expected underwriting discounts and other expenses. During the months of August and September, we hedged the treasury rate on $250 million of the offering resulting in a cash payment to us of $1.6 million that will reduce our interest expense over the life of the notes.

2007 GUIDANCE

We are increasing our full-year 2007 guidance range for FFO before impairments, acquisitions and capital transactions and are changing the range from between $2.03 and $2.07 per share to between $2.07 and $2.09 per share, inclusive of the $0.02 per share of non-recurring FFO from the collection of previously reserved rent, interest and late fees noted a
'/>"/>

SOURCE Nationwide Health Properties, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Steven Reinberg HealthDay ... A potential vaccine to protect children from the worldwide scourge ... Asian children. While the vaccine only prevented dengue fever ... full series of three shots, it protected more than 88 ... dengue fever can lead to hospitalization, and sometimes death. ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... in Wheatland, CA. In the Sacramento California area there ... Train Amphitheatre can do for music fans. The venue has ... of its existence and can seat 18,500 fans each night. ... metro area) will host the “That’s My Kind of Night” ...
(Date:7/11/2014)... 11, 2014 Europe is one of ... large cultivated-and hence, irrigated land area. The agricultural sector ... accounting for around 30.0% of the total water use. ... in the southern region, but far from negligible in ... accounts for over 60.0% of the water use in ...
(Date:7/11/2014)... have been trying to unravel mechanisms that guide function ... generate all blood cells including our immune system. The ... they can only be found in the bone marrow ... culture dish. Now a group of scientists from Dresden ... Universitt Dresden) was able to generate a mouse model ...
(Date:7/11/2014)... Experience Mayan heritage and enjoy the spirit ... the luxury all-inclusive AAA Five Diamond Grand Velas Riviera ... ecological family tour where guests learn about local flora ... Tour at the Mayan archeological site of Coba. Guests ... the Yucatan and the only pyramid people are still ...
Breaking Medicine News(10 mins):Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3Health News:Opening-up the stem cell niche 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3
... (Aug. 25, 2009) The Henry M. Jackson Foundation ... three promising Uniformed Services University of the Health Sciences ... year. The program, established in 1988, is comprised of ... Hemming Fellowship. Each fellow receives a stipend and travel ...
... The University of Nottingham and Health Protection Agency East Midlands ... after being commissioned as part of the government,s response to ... long someone is contagious for and advise on a ,safe ... by Professor Jonathan Nguyen Van Tam of the University of ...
... YORK, August 25, 2009 -- Charleen T. Chu, MD, ... David M. Sabatini, MD, PhD, associate professor, Massachusetts Institute ... in Aging Research. Sponsored by The Ellison Medical ... scientists whose research has great potential in advancing understanding ...
... , , SAN ... of Bone and Joint Surgery demonstrates that use of ... effective than both DuraPrep and povidone-iodine at eliminating overall bacteria ... chlorhexidine gluconate and 70 percent isopropyl alcohol), only seven percent ...
... , , , , ... Judd is speaking up for those struggling with chronic pain -- a ... combined. Judd is lending her voice to the national education program ... instpain.com ) to raise awareness about the urgent need to ...
... SAN RAFAEL, Calif., Aug. 25 TBI/Tissue Banks International, one of ... Services (NWTS), a Puget Sound Blood Center program, have entered into ... surgeons and hospitals that rely on them for transplantable tissue. ... immediately, allows TBI to distribute tissue recovered and processed by NWTS ...
Cached Medicine News:Health News:Henry M. Jackson Foundation names fellowship award winners 2Health News:Nottingham scientists commissioned for urgent swine flu research 2Health News:Ellison Medical Foundation awards more than $1 million to mid-career scientists 2Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 2Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 3Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 4Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 5Health News:Country Legend Naomi Judd Joins 'Partners Against Pain' 2Health News:Country Legend Naomi Judd Joins 'Partners Against Pain' 3Health News:TBI/Tissue Banks International and Northwest Tissue Services Announce Collaborative Distribution Agreement 2
(Date:7/11/2014)... July 11, 2014 According to ... "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization ... and Forecast, 2013-2019" the global endoscopy devices market was ... expected to grow at a CAGR of 6.8% from ... USD 36.9 billion in 2019. Browse the ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... study results also demonstrate the longest duration of consistently ... levels shown by a cervical cancer vaccine, TAMPA, ... GSK ) cervical cancer candidate vaccine,CERVARIX(R) provides significant ... human papillomavirus types for nearly six and a half,years, ...
... SOUTH SAN FRANCISCO, Calif., March 10 ... clinical-stage biopharmaceutical,company focused on the discovery, development ... positive interim data,from the company,s ongoing Phase ... SNS-595, in platinum-resistant ovarian cancer patients., ...
Cached Medicine Technology:GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 2GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 3GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 4GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 5GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 6Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 3Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 4Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 5
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: